State of New Jersey Common Pension Fund D’s ARS Pharmaceuticals SPRY Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$149K	Buy	+18,576	New	+$178K	﹤0.01%	1543

Other funds holding SPRY

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State of New Jersey Common Pension Fund D's SPRY Position: Q1 2026 in Review

State of New Jersey Common Pension Fund D opened a new position in ARS Pharmaceuticals (SPRY) in Q1 2026: 18,576 shares worth $149K. The stake represents ﹤0.01% of the portfolio and ranks #1543 among its holdings.

202 funds tracked by Wall St. Rank hold SPRY as of Q1 2026.

State of New Jersey Common Pension Fund D held 18,576 shares of ARS Pharmaceuticals worth $149K as of Q1 2026.
ARS Pharmaceuticals was a new State of New Jersey Common Pension Fund D position in Q1 2026.
ARS Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q1 2026, its #1543 holding.
202 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q1 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q1 2026, filed 5 May 2026.